Computerized-Adaptive vs. Traditional Ratings of Depression and Suicidal Thoughts: An Assay Sensitivity Pilot Study in a Ketamine Clinical Trial

被引:9
|
作者
Grunebaum, Michael F. [1 ,2 ]
Mann, J. John [1 ,2 ]
Galfalvy, Hanga C. [1 ,2 ]
Gibbons, Robert D. [3 ,4 ]
机构
[1] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY 10027 USA
[2] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
[3] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA
[4] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA
来源
FRONTIERS IN PSYCHIATRY | 2021年 / 12卷
基金
美国国家卫生研究院;
关键词
suicide assessment; depression scale; clinical trial; assay sensitivity; signal to noise; SCALE;
D O I
10.3389/fpsyt.2021.602976
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
There is a public health need for improved suicide risk assessment tools. This pilot methodology study compared the assay sensitivity of computerized adaptive tests (CAT) of depression and suicidal ideation vs. traditional ratings in a randomized trial subgroup. The last 20 persons to enroll in a published ketamine trial in suicidal depression were studied. This subgroup received traditional and CAT ratings at baseline, 24 h post-infusion and follow-up week 2, 4, and 6: Hamilton Depression Rating Scale, Beck Depression Inventory, and Beck Scale for Suicidal Ideation vs. the CAT-Depression Inventory and CAT-Suicide Scale. Results showed larger effect sizes (ES) for CAT compared with traditional clinician-rated and self-report scales. Coefficients of variation for baseline measurements were lower for CAT compared with traditional scales. This is the first study to show that CAT may have greater assay sensitivity for treatment effects, particularly for suicidal ideation, compared with traditional clinician-rated and non-adaptive self-rated scales in a randomized trial. The findings suggest CAT can enable quick long-term follow-up assessments via cellphone, tablet, or computer while minimizing response bias due to repeated measurement of the same symptom items.
引用
收藏
页数:7
相关论文
共 15 条
  • [1] Ketamine metabolite pilot study in a suicidal depression trial
    Grunebaum, Michael F.
    Galfalvy, Hanga C.
    Choo, Tse-Hwei
    Parris, Michelle S.
    Burke, Ainsley K.
    Suckow, Raymond F.
    Cooper, Thomas B.
    Mann, J. John
    JOURNAL OF PSYCHIATRIC RESEARCH, 2019, 117 : 129 - 134
  • [2] Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial
    Grunebaum, Michael F.
    Ellis, Steven P.
    Keilp, John G.
    Moitra, Vivek K.
    Cooper, Thomas B.
    Marver, Julia E.
    Burke, Ainsley K.
    Milak, Matthew S.
    Sublette, M. Elizabeth
    Oquendo, Maria A.
    Mann, J. John
    BIPOLAR DISORDERS, 2017, 19 (03) : 176 - 183
  • [3] Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
    Grunebaum, Michael F.
    Galfalvy, Hanga C.
    Choo, Tse-Hwei
    Keilp, John G.
    Moitra, Vivek K.
    Parris, Michelle S.
    Marver, Julia E.
    Burke, Ainsley K.
    Milak, Matthew S.
    Sublette, M. Elizabeth
    Oquendo, Maria A.
    Mann, J. John
    AMERICAN JOURNAL OF PSYCHIATRY, 2018, 175 (04): : 327 - 335
  • [4] Ketamine metabolite pilot study in a suicidal depression trial (vol 117, pg 129, 2019)
    Michael, Grunebaum F.
    Galfalvy, Hanga C.
    Choo, Tse-Hwei
    Parris, Michelle S.
    Burke, Ainsley K.
    Suckow, Raymond F.
    Cooper, Thomas B.
    Mann, J. John
    JOURNAL OF PSYCHIATRIC RESEARCH, 2019, 119 : 32 - 32
  • [5] Pilot Randomized Clinical Trial of an SSRI vs Bupropion: Effects on Suicidal Behavior, Ideation, and Mood in Major Depression
    Grunebaum, Michael F.
    Ellis, Steven P.
    Duan, Naihua
    Burke, Ainsley K.
    Oquendo, Maria A.
    Mann, J. John
    NEUROPSYCHOPHARMACOLOGY, 2012, 37 (03) : 697 - 706
  • [6] Pilot Randomized Clinical Trial of an SSRI vs Bupropion: Effects on Suicidal Behavior, Ideation, and Mood in Major Depression
    Michael F Grunebaum
    Steven P Ellis
    Naihua Duan
    Ainsley K Burke
    Maria A Oquendo
    J John Mann
    Neuropsychopharmacology, 2012, 37 : 697 - 706
  • [7] Neural Correlates of the DEEPP (Anti-suicidal Response to Ketamine in Treatment-Resistant Bipolar Depression) Study: Protocol for a Pilot, Open-Label Clinical Trial
    Knyahnytska, Yuliya
    Zomorrodi, Reza
    Kaster, Tyler
    Voineskos, Daphne
    Trevizol, Alisson
    Blumberger, Daniel
    JMIR RESEARCH PROTOCOLS, 2023, 12
  • [8] Neural correlates of anti-suiciDal rEsponse to kEtamine in treatment-resistant biPolar depression (DEEPP-Study): Protocol for a Pilot, Open-Label Clinical Trial
    Knyahnytska, Yuliya
    Zomorrodi, Reza
    Kaster, Tyler
    Voineskos, Daphnei
    Trevizol, Alisson
    Blumberger, Daniel
    JOURNAL OF ECT, 2024, 40 (03) : E25 - E25
  • [9] Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial
    Cigognini, Marco Aurelio
    Guirado, Alia Garrudo
    van de Meene, Denise
    Schneider, Monica Andreia
    Salomon, Monica Sarah
    de Alexandria, Vinicius Santana
    Adriano, Juliana Pisseta
    Thaler, Ana Maria
    Fernandes, Fernando dos Santos
    Carneiro, Adriana
    Moreno, Ricardo Alberto
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [10] Pilot study: Short term effect of low vs. moderate intensity exercise. A randomized clinical controlled trial
    Wiechmann, April
    Taylor, Daniel
    Gardner, Christie
    Bramoweth, Adam
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S158 - S158